print PRINT

SCIENCE > Health

Japan likely to allow emergency use of Merck’s COVID-19 pill

  • October 4, 2021
  • , Mainichi
  • JMH Summary

Mainichi front-paged the finding that the GOJ has launched negotiations with U.S. pharmaceutical giant Merck to procure its experimental oral drug for the novel coronavirus as early as this year. According to the daily, the Health Ministry is likely to give the medicine, which is called molnupiravir, exceptional approval in December if the U.S. FDA issues emergency use authorization next month. The oral antiviral drug is expected to become extremely beneficial in the fight against COVID-19 since a pill that is effective in preventing mild and moderate cases from leading to dire outcomes will greatly reduce stress on healthcare capacities because it is easy to prescribe and take.

  • Ambassador
  • Ukraine
  • COVID-19
  • Trending Japan